世界の麻薬市場2022年:市場規模予測(~2028年)

■ 英語タイトル:Global Narcotic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート(データ管理コード:GIR22NO19448)■ 発行会社/調査会社:GlobalInfoResearch
■ 商品コード:GIR22NO19448
■ 発行日:2022年11月(※2025年版があります。お問い合わせください。)
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:100
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(注文後2-3日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の麻薬市場2022年:市場規模予測(~2028年)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

麻薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の麻薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

麻薬市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ファストスリープ、保定寧混合物、ルミアンバオ、その他

用途別セグメントは次のように区分されます。
・病院、診療所

世界の麻薬市場の主要な市場プレーヤーは以下のとおりです。
・AstraZeneca、MPAPHARMA、Johnson & Johnson、Roche、LGC Group、Hikma Pharmaceuticals、Baxter、Maruishi、AuroMedics、Piramal Healthcare、ABbVie、Dechra

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、麻薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な麻薬メーカーの企業概要、2019年~2022年までの麻薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な麻薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別麻薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの麻薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での麻薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および麻薬の産業チェーンを掲載しています。
・第13、14、15章では、麻薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 麻薬の概要
- 種類別分析(2017年vs2021年vs2028年):ファストスリープ、保定寧混合物、ルミアンバオ、その他
- 用途別分析(2017年vs2021年vs2028年):病院、診療所
- 世界の麻薬市場規模・予測
- 世界の麻薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- AstraZeneca、MPAPHARMA、Johnson & Johnson、Roche、LGC Group、Hikma Pharmaceuticals、Baxter、Maruishi、AuroMedics、Piramal Healthcare、ABbVie、Dechra
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:ファストスリープ、保定寧混合物、ルミアンバオ、その他
・用途別分析2017年-2028年:病院、診療所
・麻薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・麻薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・麻薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・麻薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・麻薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Narcotic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Narcotic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Narcotic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Fast Sleep New segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Narcotic Drugs include AstraZeneca, MPAPHARMA, Johnson & Johnson, Roche, and LGC Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Narcotic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fast Sleep New
Baodingning Mixture
Lumianbao
Other Compound Anesthetics
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Narcotic Drugs market are listed below:
AstraZeneca
MPAPHARMA
Johnson & Johnson
Roche
LGC Group
Hikma Pharmaceuticals
Baxter
Maruishi
AuroMedics
Piramal Healthcare
ABbVie
Dechra
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Narcotic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Narcotic Drugs, with price, sales, revenue and global market share of Narcotic Drugs from 2019 to 2022.
Chapter 3, the Narcotic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Narcotic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Narcotic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Narcotic Drugs.
Chapter 13, 14, and 15, to describe Narcotic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次(コンテンツ)***

1 Market Overview
1.1 Narcotic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Narcotic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Fast Sleep New
1.2.3 Baodingning Mixture
1.2.4 Lumianbao
1.2.5 Other Compound Anesthetics
1.3 Market Analysis by Application
1.3.1 Overview: Global Narcotic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Narcotic Drugs Market Size & Forecast
1.4.1 Global Narcotic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Narcotic Drugs Sales in Volume (2017-2028)
1.4.3 Global Narcotic Drugs Price (2017-2028)
1.5 Global Narcotic Drugs Production Capacity Analysis
1.5.1 Global Narcotic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Narcotic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Narcotic Drugs Market Drivers
1.6.2 Narcotic Drugs Market Restraints
1.6.3 Narcotic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Narcotic Drugs Product and Services
2.1.4 AstraZeneca Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 MPAPHARMA
2.2.1 MPAPHARMA Details
2.2.2 MPAPHARMA Major Business
2.2.3 MPAPHARMA Narcotic Drugs Product and Services
2.2.4 MPAPHARMA Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Narcotic Drugs Product and Services
2.3.4 Johnson & Johnson Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Narcotic Drugs Product and Services
2.4.4 Roche Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 LGC Group
2.5.1 LGC Group Details
2.5.2 LGC Group Major Business
2.5.3 LGC Group Narcotic Drugs Product and Services
2.5.4 LGC Group Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hikma Pharmaceuticals
2.6.1 Hikma Pharmaceuticals Details
2.6.2 Hikma Pharmaceuticals Major Business
2.6.3 Hikma Pharmaceuticals Narcotic Drugs Product and Services
2.6.4 Hikma Pharmaceuticals Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Baxter
2.7.1 Baxter Details
2.7.2 Baxter Major Business
2.7.3 Baxter Narcotic Drugs Product and Services
2.7.4 Baxter Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Maruishi
2.8.1 Maruishi Details
2.8.2 Maruishi Major Business
2.8.3 Maruishi Narcotic Drugs Product and Services
2.8.4 Maruishi Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 AuroMedics
2.9.1 AuroMedics Details
2.9.2 AuroMedics Major Business
2.9.3 AuroMedics Narcotic Drugs Product and Services
2.9.4 AuroMedics Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Piramal Healthcare
2.10.1 Piramal Healthcare Details
2.10.2 Piramal Healthcare Major Business
2.10.3 Piramal Healthcare Narcotic Drugs Product and Services
2.10.4 Piramal Healthcare Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 ABbVie
2.11.1 ABbVie Details
2.11.2 ABbVie Major Business
2.11.3 ABbVie Narcotic Drugs Product and Services
2.11.4 ABbVie Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Dechra
2.12.1 Dechra Details
2.12.2 Dechra Major Business
2.12.3 Dechra Narcotic Drugs Product and Services
2.12.4 Dechra Narcotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Narcotic Drugs Breakdown Data by Manufacturer
3.1 Global Narcotic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Narcotic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Narcotic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Narcotic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Narcotic Drugs Manufacturer Market Share in 2021
3.5 Global Narcotic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Narcotic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Narcotic Drugs Market Size by Region
4.1.1 Global Narcotic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Narcotic Drugs Revenue by Region (2017-2028)
4.2 North America Narcotic Drugs Revenue (2017-2028)
4.3 Europe Narcotic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Narcotic Drugs Revenue (2017-2028)
4.5 South America Narcotic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Narcotic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Narcotic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Narcotic Drugs Revenue by Type (2017-2028)
5.3 Global Narcotic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Narcotic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Narcotic Drugs Revenue by Application (2017-2028)
6.3 Global Narcotic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Narcotic Drugs Sales by Type (2017-2028)
7.2 North America Narcotic Drugs Sales by Application (2017-2028)
7.3 North America Narcotic Drugs Market Size by Country
7.3.1 North America Narcotic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Narcotic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Narcotic Drugs Sales by Type (2017-2028)
8.2 Europe Narcotic Drugs Sales by Application (2017-2028)
8.3 Europe Narcotic Drugs Market Size by Country
8.3.1 Europe Narcotic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Narcotic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Narcotic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Narcotic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Narcotic Drugs Market Size by Region
9.3.1 Asia-Pacific Narcotic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Narcotic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Narcotic Drugs Sales by Type (2017-2028)
10.2 South America Narcotic Drugs Sales by Application (2017-2028)
10.3 South America Narcotic Drugs Market Size by Country
10.3.1 South America Narcotic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Narcotic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Narcotic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Narcotic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Narcotic Drugs Market Size by Country
11.3.1 Middle East & Africa Narcotic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Narcotic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Narcotic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Narcotic Drugs
12.3 Narcotic Drugs Production Process
12.4 Narcotic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Narcotic Drugs Typical Distributors
13.3 Narcotic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Narcotic Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Narcotic Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Narcotic Drugs Product and Services
Table 6. AstraZeneca Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. MPAPHARMA Basic Information, Manufacturing Base and Competitors
Table 8. MPAPHARMA Major Business
Table 9. MPAPHARMA Narcotic Drugs Product and Services
Table 10. MPAPHARMA Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Narcotic Drugs Product and Services
Table 14. Johnson & Johnson Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Narcotic Drugs Product and Services
Table 18. Roche Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. LGC Group Basic Information, Manufacturing Base and Competitors
Table 20. LGC Group Major Business
Table 21. LGC Group Narcotic Drugs Product and Services
Table 22. LGC Group Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Hikma Pharmaceuticals Major Business
Table 25. Hikma Pharmaceuticals Narcotic Drugs Product and Services
Table 26. Hikma Pharmaceuticals Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Baxter Basic Information, Manufacturing Base and Competitors
Table 28. Baxter Major Business
Table 29. Baxter Narcotic Drugs Product and Services
Table 30. Baxter Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Maruishi Basic Information, Manufacturing Base and Competitors
Table 32. Maruishi Major Business
Table 33. Maruishi Narcotic Drugs Product and Services
Table 34. Maruishi Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. AuroMedics Basic Information, Manufacturing Base and Competitors
Table 36. AuroMedics Major Business
Table 37. AuroMedics Narcotic Drugs Product and Services
Table 38. AuroMedics Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Piramal Healthcare Basic Information, Manufacturing Base and Competitors
Table 40. Piramal Healthcare Major Business
Table 41. Piramal Healthcare Narcotic Drugs Product and Services
Table 42. Piramal Healthcare Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. ABbVie Basic Information, Manufacturing Base and Competitors
Table 44. ABbVie Major Business
Table 45. ABbVie Narcotic Drugs Product and Services
Table 46. ABbVie Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Dechra Basic Information, Manufacturing Base and Competitors
Table 48. Dechra Major Business
Table 49. Dechra Narcotic Drugs Product and Services
Table 50. Dechra Narcotic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Narcotic Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Narcotic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Narcotic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Narcotic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Narcotic Drugs Production Site of Key Manufacturer
Table 56. Narcotic Drugs New Entrant and Capacity Expansion Plans
Table 57. Narcotic Drugs Mergers & Acquisitions in the Past Five Years
Table 58. Global Narcotic Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Global Narcotic Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Global Narcotic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Narcotic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Narcotic Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Global Narcotic Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Global Narcotic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Narcotic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Narcotic Drugs Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Narcotic Drugs Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Narcotic Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Global Narcotic Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Global Narcotic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Narcotic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Narcotic Drugs Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Narcotic Drugs Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Narcotic Drugs Sales by Country (2017-2022) & (K Units)
Table 75. North America Narcotic Drugs Sales by Country (2023-2028) & (K Units)
Table 76. North America Narcotic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Narcotic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Narcotic Drugs Sales by Type (2017-2022) & (K Units)
Table 79. North America Narcotic Drugs Sales by Type (2023-2028) & (K Units)
Table 80. North America Narcotic Drugs Sales by Application (2017-2022) & (K Units)
Table 81. North America Narcotic Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Europe Narcotic Drugs Sales by Country (2017-2022) & (K Units)
Table 83. Europe Narcotic Drugs Sales by Country (2023-2028) & (K Units)
Table 84. Europe Narcotic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Narcotic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Narcotic Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Europe Narcotic Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Europe Narcotic Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Europe Narcotic Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Narcotic Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Narcotic Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Narcotic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Narcotic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Narcotic Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Narcotic Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Narcotic Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Narcotic Drugs Sales by Application (2023-2028) & (K Units)
Table 98. South America Narcotic Drugs Sales by Country (2017-2022) & (K Units)
Table 99. South America Narcotic Drugs Sales by Country (2023-2028) & (K Units)
Table 100. South America Narcotic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Narcotic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Narcotic Drugs Sales by Type (2017-2022) & (K Units)
Table 103. South America Narcotic Drugs Sales by Type (2023-2028) & (K Units)
Table 104. South America Narcotic Drugs Sales by Application (2017-2022) & (K Units)
Table 105. South America Narcotic Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Narcotic Drugs Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Narcotic Drugs Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Narcotic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Narcotic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Narcotic Drugs Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Narcotic Drugs Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Narcotic Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Narcotic Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Narcotic Drugs Raw Material
Table 115. Key Manufacturers of Narcotic Drugs Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Narcotic Drugs Typical Distributors
Table 119. Narcotic Drugs Typical Customers
List of Figures
Figure 1. Narcotic Drugs Picture
Figure 2. Global Narcotic Drugs Revenue Market Share by Type in 2021
Figure 3. Fast Sleep New
Figure 4. Baodingning Mixture
Figure 5. Lumianbao
Figure 6. Other Compound Anesthetics
Figure 7. Global Narcotic Drugs Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Narcotic Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Narcotic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Narcotic Drugs Sales (2017-2028) & (K Units)
Figure 13. Global Narcotic Drugs Price (2017-2028) & (US$/Unit)
Figure 14. Global Narcotic Drugs Production Capacity (2017-2028) & (K Units)
Figure 15. Global Narcotic Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Narcotic Drugs Market Drivers
Figure 17. Narcotic Drugs Market Restraints
Figure 18. Narcotic Drugs Market Trends
Figure 19. Global Narcotic Drugs Sales Market Share by Manufacturer in 2021
Figure 20. Global Narcotic Drugs Revenue Market Share by Manufacturer in 2021
Figure 21. Narcotic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Narcotic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Narcotic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Narcotic Drugs Sales Market Share by Region (2017-2028)
Figure 25. Global Narcotic Drugs Revenue Market Share by Region (2017-2028)
Figure 26. North America Narcotic Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Europe Narcotic Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Narcotic Drugs Revenue (2017-2028) & (USD Million)
Figure 29. South America Narcotic Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Narcotic Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Global Narcotic Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Narcotic Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Narcotic Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Narcotic Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Narcotic Drugs Revenue Market Share by Application (2017-2028)
Figure 36. Global Narcotic Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Narcotic Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America Narcotic Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Narcotic Drugs Sales Market Share by Country (2017-2028)
Figure 40. North America Narcotic Drugs Revenue Market Share by Country (2017-2028)
Figure 41. United States Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Narcotic Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Narcotic Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Narcotic Drugs Sales Market Share by Country (2017-2028)
Figure 47. Europe Narcotic Drugs Revenue Market Share by Country (2017-2028)
Figure 48. Germany Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Narcotic Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Narcotic Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Narcotic Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Narcotic Drugs Revenue Market Share by Region (2017-2028)
Figure 57. China Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Narcotic Drugs Sales Market Share by Type (2017-2028)
Figure 64. South America Narcotic Drugs Sales Market Share by Application (2017-2028)
Figure 65. South America Narcotic Drugs Sales Market Share by Country (2017-2028)
Figure 66. South America Narcotic Drugs Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Narcotic Drugs Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Narcotic Drugs Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Narcotic Drugs Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Narcotic Drugs Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Narcotic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Narcotic Drugs in 2021
Figure 78. Manufacturing Process Analysis of Narcotic Drugs
Figure 79. Narcotic Drugs Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR22NO19448 )"世界の麻薬市場2022年:市場規模予測(~2028年)" (英文:Global Narcotic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。